Candel Therapeutics, Inc. (CADL) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $125.19M | +17.2% |
| 2024 | $106.87M | +159.4% |
| 2023 | $41.20M | -47.0% |
| 2022 | $77.69M | -12.9% |
| 2021 | $89.20M | +133.0% |
| 2020 | $38.28M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $125.19M | +17.2% |
| 2024 | $106.87M | +159.4% |
| 2023 | $41.20M | -47.0% |
| 2022 | $77.69M | -12.9% |
| 2021 | $89.20M | +133.0% |
| 2020 | $38.28M | — |